Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD pl... Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products. Mehr anzeigen
Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share PR Newswire JOHNSON CITY, Tenn., Dec. 12, 2024 Board of Directors...
Crown Laboratories, Inc. (“Crown”), a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc. (“Revance”) (NASDAQ: RVNC), a biotechnology company aimed...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 3.07 | 3.085 | 3.06 | 872086 | 3.06983945 | CS |
| 4 | -0.54 | -14.9584487535 | 3.61 | 4.17 | 3.01 | 3393812 | 3.15305127 | CS |
| 12 | -2.15 | -41.1877394636 | 5.22 | 6.02 | 3.01 | 2490701 | 3.92866282 | CS |
| 26 | 0.5 | 19.4552529183 | 2.57 | 6.65 | 2.395 | 3586584 | 5.22074345 | CS |
| 52 | -5.94 | -65.9267480577 | 9.01 | 9.745 | 2.3 | 2747547 | 5.01585849 | CS |
| 156 | -13.49 | -81.461352657 | 16.56 | 37.98 | 2.3 | 1772423 | 12.70810261 | CS |
| 260 | -13.15 | -81.0727496917 | 16.22 | 37.98 | 2.3 | 1319251 | 14.6776041 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
